About IntegReview IRB
IntegReview IRB is a company based in Austin (United States) founded in 1999 by Lynn A Meyer was acquired by Advarra in November 2020. IntegReview IRB offers products and services including CIRBI, OnCore, Clinical Conductor, and eReg. IntegReview IRB operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
- Headquarter Austin, United States
- Founders Lynn A Meyer
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IntegReview IRB
IntegReview IRB offers a comprehensive portfolio of products and services, including CIRBI, OnCore, Clinical Conductor, and eReg.
Platform for real-time IRB review and document management.
System for managing clinical trial operations and data.
Tool for regulatory compliance in clinical research.
Platform for electronic consent and regulatory processes.
Funding Insights of IntegReview IRB
Detailed funding history for IntegReview IRB
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in IntegReview IRB
IntegReview IRB has secured backing from 1 investor. Prominent investors backing the company include Advarra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global research compliance services including IRB and consulting are provided.
|
Locked | Locked | Locked |
Investor details for IntegReview IRB
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IntegReview IRB
Investment portfolio details for IntegReview IRB
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IntegReview IRB
Detailed financials for IntegReview IRB
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Integreview Irb Comparisons
Peer comparison for IntegReview IRB
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IntegReview IRB
IntegReview IRB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of IntegReview IRB
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Integreview Irb
Complete news archive for IntegReview IRB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntegReview IRB
IntegReview IRB was founded in 1999.
IntegReview IRB is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Melissa Meyer is the current CEO of IntegReview IRB.
IntegReview IRB was established in 1999 in Austin, United States, as a provider of clinical research services focused on the biopharmaceutical sector. Institutional review board functions are handled, including protocol assessments and ethical oversight for trials. Operations support biopharma clients through compliance and regulatory guidance. The company is led by founder Lynn A. Meyer and CEO Melissa Meyer, with activities centered in the U.S.
IntegReview IRB's top competitors include Emmes, Syneos Health and ClinChoice.
IntegReview IRB offers CIRBI, OnCore, Clinical Conductor, and eReg.
IntegReview IRB has 1 investor. Key investors include Advarra.